ChronoScale stock analysis
Want to see CHRN full AI Analyst Report?
ChronoScale (CHRN) Stock Price & Analysis
CHRN Stock Chart & Stats
- Day’s Range
- $9.05 - $10.32
- 52-Week Range
- $3.50 - $30.00
- Previous Close
- $9.95
- Volume
- N/A
- Average Volume (3M)
- 153.38K
- Market Cap
- $1.37B
- Enterprise Value
- $2.74B
- Total Cash (Recent Filing)
- $15.22M
- Total Debt (Recent Filing)
- $111.06M
- Price to Earnings (P/E)
- ―
- Beta
- 1.57
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Exceptional Revenue Growth
Revenue expansion of roughly 341% demonstrates strong recent demand and materially increases the potential scale of the business. Maintaining gross margin near 53% during this growth suggests the offering has reasonable unit economics, although continued execution is needed to convert scale into profits.
Positive Operating Cash Flow
The move to positive operating and free cash flow improves internal funding capacity and reduces immediate reliance on external capital. If sustained, cash generation could support deployments and operating needs while gradually improving financial flexibility despite the company’s continuing accounting losses.
Focused AI Infrastructure Pipeline
Selling Ekso Bionics and expanding AI infrastructure contracts concentrates management attention and capital on the accelerated-compute platform. The larger contracted pipeline and Microsoft deployment provide a clearer strategic focus and could support recurring infrastructure growth as projects are delivered.
Bears Say
Deepening Operating Losses
The company has not yet demonstrated operating leverage: rapid revenue growth is being outweighed by a cost structure that produces materially larger losses. Persistent negative profitability can consume capital, limit reinvestment capacity, and weaken the durability of the growth model.
Rising Leverage
The sharp increase in leverage raises financial risk while returns remain negative, leaving the enlarged debt burden unsupported by current earnings. Higher obligations can constrain capital allocation and make the company more dependent on successful growth, refinancing, or continued cash-flow improvement.
Deployment And Funding Execution Risk
A stronger contracted pipeline does not eliminate the challenge of building and deploying large-scale AI infrastructure. Delays or insufficient funding could defer revenue realization, increase capital requirements, and prevent the strategic focus from translating into durable operating results.
ChronoScale News
CHRN FAQ
What was ChronoScale’s price range in the past 12 months?
What is ChronoScale’s market cap?
When is ChronoScale’s upcoming earnings report date?
How were ChronoScale’s earnings last quarter?
Is ChronoScale overvalued?
Does ChronoScale pay dividends?
What is ChronoScale’s EPS estimate?
How many shares outstanding does ChronoScale have?
What happened to ChronoScale’s price movement after its last earnings report?
Which hedge fund is a major shareholder of ChronoScale?
What is the TipRanks Smart Score and how is it calculated?
ChronoScale Stock Smart Score
Company Description
ChronoScale
ChronoScale Corporation designs and develops a compute platform to support artificial intelligence (AI) workloads. The company focuses on large-scale deployments and provides dedicated compute environments engineered for performance, consistency, and long-term operational execution. The company is based in Dallas, Texas. ChronoScale Corporation operates as a subsidiary of Applied Digital Corporation.
- Sector
- Technology
- Industry
- Information Technology Services
- CEO
- Ying Cenly Chen
- Employees
- 86
- Website
- chronoscale.com
- Address
- 3811 Turtle Creek Blvd., Dallas, TX, 75219, US
ChronoScale (CHRN) Earnings & Revenues
CHRN Earnings Call
Earnings Call SentimentNegative
The earnings call highlighted significant challenges, including a major decline in revenue and gross margin, alongside an increased net loss. Despite these challenges, there were positive developments in the personal health segment, strategic partnerships, and AI initiatives. However, the financial setbacks appear to overshadow the positive developments.
View all CHRN earnings summariesCHRN Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 3 | 14 |
| Technical Analysis | 5 | 3 | 2 |
| Moving Averages | 0 | 0 | 12 |













